Inventor · disambiguated record
Scott Ganser
Also filed as: GANSER SCOTT S
5 granted patents·7 pending applications·134 citations·filing 2000–2009
85Inventor score
Top patents by PatentIndex Score
12 records- 0194US7196118B2Amidino compounds useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2005·Granted Mar 27, 2007·24 cites·2 claims
- 0293US6586474B2Amidino compounds useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2001·Granted Jul 1, 2003·46 cites·108 claims
- 0393US6403830B2Amidino compound and salts thereof useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2001·Granted Jun 11, 2002·39 cites·39 claims
- 0486US6914158B2Amidino compounds useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2004·Granted Jul 5, 2005·17 cites·14 claims
- 0578US7102013B2Methods of making amidino compounds useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2002·Granted Sep 5, 2006·8 cites·18 claims
- 0648US2005261261A1Eplerenone drug substance having high phase purityPHARMACIA CORP·Filed 2005·Application pending·0 cites
- 0745US2009149431A1Eplerenone Drug Substance Having High Phase PurityBARTON KATHLEEN P·Filed 2009·Application pending·0 cites
- 0843US2005159594A1Eplerenone crystal form exhibiting enhanced dissolution ratePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0942US2003083493A1Eplerenone drug substance having high phase purityFiled 2002·Application pending·0 cites
- 1041US2005267302A1Eplerenone crystalline form exhibiting enhanced dissolution rateSEARLE & CO·Filed 2003·Application pending·0 cites
- 1134US2002045746A1Eplerenone crystalline formFiled 2000·Application pending·0 cites
- 1234US2002038021A1Eplerenone crystalline form exhibiting enhanced dissolution rateFiled 2000·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →